Mergers & Acquisitions Mergers & Acquisitions

Altria stopped research on e-vapor products with Juul investment, executive testifies, but R&D showed no promise of near-term pay-off

By Robert Thomason
  • 15 Jun 2021 18:23
  • 15 Jun 2021 18:23
Altria's development of e-vapor products came to an end when the firm agreed to acquire 35 percent of Juul Labs, the Altria vice president for that development testified today in an antitrust trial challenging the acquisition. But he also said that Altria's e-vapor products lagged so seriously that it would have

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News